Advertisement

Rheumatology International

, 29:383 | Cite as

Association of (−1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms)

  • I. Ömer  BarlasEmail author
  • Melek Sezgin
  • M. Emin Erdal
  • Günsah Sahin
  • Handan Camdeviren Ankarali
  • Zühal Mert Altintas
  • Ebru Türkmen
Original Article

Abstract

The aim of this study was to investigate whether functional polymorphisms in the promoter of matrix metalloproteinase-1 (MMP-1), MMP-2 and MMP-9 genes were associated with susceptibility to knee osteoarthritis in the Turkish population. The MMP-1 −1,607 1G/2G (rs1799750), MMP-2 −1,306 C/T (rs243865), and MMP-9 −1,562 C/T (rs3918242) polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism assay in 157 patients diagnosed with knee osteoarthritis based on the criteria of American College of Rheumatology and in 84 controls in Mersin, Turkey. Genotype distributions and allele frequencies of MMP-1, MMP-2, and MMP-9 gene polymorphisms were compared between the patients and controls. There were significant differences between the groups regarding the genotype distribution of MMP-1 polymorphism ( = 0.001). The frequencies of 1G/1G and 1G/2G genotypes were significantly higher in the knee osteoarthritis than in the controls (P = 0.002, and P =  0.006, respectively). In addition, 1G allele frequency of MMP-1 gene was higher in the patients than in the control group (P = 0.0001). The genotype distributions and allele frequencies of MMP-2 and MMP-9 gene polymorphisms did not differ between the osteoarthritis and the control groups (P > 0.05). These findings suggest that the −1,607 1G/2G polymorphism in the MMP-1 gene may contribute to susceptibility to knee osteoarthritis in the Turkish population.

Keywords

Knee osteoarthritis MMP-1 MMP-2 MMP-9 Gene polymorphism 

References

  1. 1.
    Solomon L (2001) Clinical features of osteoarthritis. In: Ruddy S, Harris ED, Sledge CB (eds) Kelley’s textbook of rheumatology. WB Saunders, Philadelphia, pp 1409–1418Google Scholar
  2. 2.
    Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR (1995) Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 96:2859–2869. doi: 10.1172/JCI118357 PubMedCrossRefGoogle Scholar
  3. 3.
    Kevorkian L, Young DA, Darrah C et al (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131–141. doi: 10.1002/art.11433 PubMedCrossRefGoogle Scholar
  4. 4.
    Murphy G, Nagase H (2008) Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? Nat Clin Pract Rheumatol 4:128–135. doi: 10.1038/ncprheum0727 PubMedCrossRefGoogle Scholar
  5. 5.
    Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–839. doi: 10.1161/01.RES.0000070112.80711.3D PubMedCrossRefGoogle Scholar
  6. 6.
    Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA (1997) Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 40:2065–2074. doi: 10.1002/art.1780401120 PubMedCrossRefGoogle Scholar
  7. 7.
    Fernandes JC, Martel-Pelletier J, Lascau-Coman V et al (1998) Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: an immunohistochemical study. J Rheumatol 25:1585–1594PubMedGoogle Scholar
  8. 8.
    Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44:2777–2789. doi :10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-HPubMedCrossRefGoogle Scholar
  9. 9.
    Flannelly J, Chambers MG, Dudhia J et al (2002) Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthritis Cartilage 10:722–733. doi: 10.1053/joca.2002.0818 PubMedCrossRefGoogle Scholar
  10. 10.
    Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44:585–594. doi :10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-CPubMedCrossRefGoogle Scholar
  11. 11.
    Hulejová H, Baresová V, Klézl Z, Polanská M, Adam M, Senolt L (2007) Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 38:151–156. doi: 10.1016/j.cyto.2007.06.001 PubMedCrossRefGoogle Scholar
  12. 12.
    Rutter JL, Mitchell TI, Butticè G et al (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321–5325PubMedGoogle Scholar
  13. 13.
    Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623–629. doi: 10.1016/S0945-053X(00)00102-5 PubMedCrossRefGoogle Scholar
  14. 14.
    Zhang B, Ye S, Herrmann SM et al (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–1794PubMedGoogle Scholar
  15. 15.
    Kanamori Y, Matsushima M, Minaguchi T et al (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMedGoogle Scholar
  16. 16.
    Nishioka Y, Kobayashi K, Sagae S et al (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91:612–615PubMedGoogle Scholar
  17. 17.
    Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H (1999) Genetic analysis of MMP3, MMP9 and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563–568. doi: 10.1006/bbrc.1999.1721 PubMedCrossRefGoogle Scholar
  18. 18.
    de Souza AP, Trevilatto PC, Scarel-Caminaga RM, Brito RB, Line SR (2003) MMP-1 promoter polymorphism: association with chronic periodontitis severity in a Brazilian population. J Clin Periodontol 30:154–158. doi: 10.1034/j.1600-051X.2003.300202.x PubMedCrossRefGoogle Scholar
  19. 19.
    Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239PubMedGoogle Scholar
  20. 20.
    Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558. doi: 10.1074/jbc.M010242200 PubMedCrossRefGoogle Scholar
  21. 21.
    Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. doi: 10.1093/nar/16.3.1215 PubMedCrossRefGoogle Scholar
  22. 22.
    Vasku A, Goldbergova M, Holla IL et al (2004) A haplotype constituted of four MMP-2 promoter polymorphisms (−1,575G/A, −1,306C/T, −790T/G and −735C/T) is associated with coronary triple-vessel disease. Matrix Biol 22:585–591. doi: 10.1016/j.matbio.2003.10.004 PubMedCrossRefGoogle Scholar
  23. 23.
    Grieu F, Li WQ, Iacopetta B (2004) Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88:197–204. doi: 10.1007/s10549-004-0595-6 PubMedCrossRefGoogle Scholar
  24. 24.
    Zhang XM, Miao XP, Xiong P et al (2004) Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population. Ai Zheng 23:1233–1237PubMedGoogle Scholar
  25. 25.
    Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260–1270. doi: 10.1093/jnci/89.17.1260 PubMedCrossRefGoogle Scholar
  26. 26.
    Fini ME, Cook JR, Mohan R, Brinckerhoff CE (1998) Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP (eds) Matrix metalloproteinases. Academic, California, pp 300–356Google Scholar
  27. 27.
    Ghilardi G, Biondi ML, Mangoni J et al (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 7:2344–2346PubMedGoogle Scholar
  28. 28.
    Kanamori Y, Matsushima M, Minaguchi T et al (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 59:4225–4227PubMedGoogle Scholar
  29. 29.
    Zhu Y, Spitz MR, Lei L, Mills GB, Wu X (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61:7825–7829PubMedGoogle Scholar
  30. 30.
    Ninomiya S, Niimi T, Shimizu S et al (2004) Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21:19–24PubMedGoogle Scholar
  31. 31.
    Kuo HP, Wang YM, Wang CH et al (2008) Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis. Tuberculosis (Edinb) 88:262–267. doi: 10.1016/j.tube.2007.08.010 CrossRefGoogle Scholar
  32. 32.
    Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41:209–214. doi: 10.1016/j.jhep.2004.04.024 PubMedCrossRefGoogle Scholar
  33. 33.
    Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558Google Scholar
  34. 34.
    Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D (2004) Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 64:7622–7628. doi: 10.1158/0008-5472.CAN-04-1521 PubMedCrossRefGoogle Scholar
  35. 35.
    Keles GC, Gunes S, Sumer AP et al (2006) Association of MMP-9 promoter gene polymorphism with chronic periodontitis. J Periodontol 77:1510–1514. doi: 10.1902/jop.2006.050378 PubMedCrossRefGoogle Scholar
  36. 36.
    Yu C, Pan K, Xing D et al (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430–6433PubMedGoogle Scholar
  37. 37.
    Matsumura S, Oue N, Nakayama H et al (2005) A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131:19–25. doi: 10.1007/s00432-004-0621-4 PubMedCrossRefGoogle Scholar
  38. 38.
    Vairaktaris E, Vassiliou S, Nkenke E et al (2008) A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 34:450–455. doi: 10.1016/j.ejso.2007.03.024 PubMedCrossRefGoogle Scholar
  39. 39.
    Sugimoto M, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T (2006) Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J Soc Gynecol Investig 13:523–529PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • I. Ömer  Barlas
    • 1
    Email author
  • Melek Sezgin
    • 2
  • M. Emin Erdal
    • 1
  • Günsah Sahin
    • 2
  • Handan Camdeviren Ankarali
    • 3
  • Zühal Mert Altintas
    • 1
  • Ebru Türkmen
    • 2
  1. 1.Department of Medical Biology and GeneticsMedical Faculty of Mersin UniversityMersinTurkey
  2. 2.Department of Physical Medicine and RehabilitationMedical Faculty of Mersin UniversityMersinTurkey
  3. 3.Department of BiostatisticsMedical Faculty of Karaelmas University ZonguldakTurkey

Personalised recommendations